Skip to content
value.today

Kezar Life Sciences, Inc. vs Moderna, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Moderna, Inc. is the larger company by market value: $90.1 B against $51 M for Kezar Life Sciences, Inc., 1767 times as much (market caps of Mar 8, 2026 for Kezar Life Sciences, Inc. and Oct 30, 2026 for Moderna, Inc.). Kezar Life Sciences, Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.
  • Both made a net loss: $54 M for Kezar Life Sciences, Inc. and $2.8 B for Moderna, Inc.
  • Moderna, Inc. employs more people: 4,700 against 56 at Kezar Life Sciences, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0342685102713702020202120222023202420252026Kezar Life Sciences, Inc. 61Moderna, Inc. 1370

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$5B$10B$14B$19B201720182019202020212022202320242025Moderna, Inc. $2B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureKezar Life Sciences, Inc.
KZR
Moderna, Inc.
MRNA · #275 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded20152010
Size
Market cap$51 M*$90.1 B
Revenue$0 M$1.9 B
Net income$-54 M▲ best$-2.8 B
Employees564,700
Valuation
Price to sales—35.7×
Price to book—10.4×
Free cash flow yield—-2.3%
Profitability
Gross margin—55.4%
Operating margin—-158.1%
Net margin—-145.2%
Return on equity—-28.9%
Growth
Revenue growth—-39.9%
Revenue growth, 3 years a year—-53.4%
Financial strength
Debt to equity—0.1×
Cash
Free cash flow margin—-106.2%
Shareholder returns
Shareholder yield—0.0%
Strength scores
Piotroski F-score—3 of 9
Altman Z-score zone—safe
Data as ofMarket cap Mar 2026Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Kezar Life Sciences, Inc. or Moderna, Inc.?

Moderna, Inc. is the larger company by market value: $90.1 B against $51 M for Kezar Life Sciences, Inc., 1767 times as much (market caps of Mar 8, 2026 for Kezar Life Sciences, Inc. and Oct 30, 2026 for Moderna, Inc.). Kezar Life Sciences, Inc.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, Kezar Life Sciences, Inc. or Moderna, Inc.?

Both made a net loss: $54 M for Kezar Life Sciences, Inc. and $2.8 B for Moderna, Inc.

Which has more employees, Kezar Life Sciences, Inc. or Moderna, Inc.?

Moderna, Inc. employs more people: 4,700 against 56 at Kezar Life Sciences, Inc.